:::

詳目顯示

回上一頁
題名:Stevens-Johnson Syndrome致病藥物的探討
書刊名:臺灣臨床藥學雜誌
作者:朱麗鈴陳昱旻蔡佩凌簡素玉
作者(外文):Chu, Li-lingChen, Yu-minTsai, Pei-lingChien, Su-yu
出版日期:2002
卷期:10:2
頁次:頁19-34
主題關鍵詞:Stevens-Johnson syndromeDrug inducedCarbamazepineAllopurinol皮膚黏膜多發性紅斑致病藥物
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(1) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:1
  • 共同引用共同引用:0
  • 點閱點閱:28
期刊論文
1.Assier, H.、Bastuji-Garin, S.、Revuz, J.、Roujeau, J. C.(1995)。Erythema multiforme with mucous membrane involvement and Stevens- Johnson syndrome are clinically different disorders with distinct causes。Archives of Dermatology,131(5),539-543。  new window
2.Garcia-Doval, I.、LeCleach, L.、Bocquet, H.、Otero, X. L.、Roujeau, J. C.(2000)。Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death?。Archives of Dermatology,136(3),323-327。  new window
3.Chan, Heng-Leong、Stern, Robert S.、Arndt, Kenneth A.、Langlois, Joe、Jick, Susan S.、Jick, Hershel、Walker, Alexander M.(1990)。The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: A population-based study with particular reference to reactions caused by drugs among outpatients。Archives of Dermatology,126(1),43-47。  new window
4.Schopf, E.、Stuhmer, A.、Rzany, B.、Victor, N.、Zentgraf, R.、Kapp, J. F.(1991)。Toxic epidermal necrolysis and Stevens-Johnson syndrome: An epidemiologic study from West Germany。Archives of Dermatology,127(6),839-842。  new window
5.Rzany, B.、Correia, O.、Kelly, J. P.、Naldi, L.、Auquier, A.、Stern, R.(1999)。Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions。Lancet,353(9171),2190-2194。  new window
6.Roujeau, J. C.(1999)。Treatment of severe drug eruptions。Journal of Dermatology,26(11),718-722。  new window
7.Roujeau, J. C.、Kelly, J. P.、Naldi, L.、Rzany, B.、Stern, R. S.、Anderson, T.、Auquier, A.、Bastuji-Garin, S.、Correia, O.、Locati, F.、Mockenhanpt, M.(1995)。Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis。New England Journal of Medicine,333(24),1600-1607。  new window
8.Sontheimer, R. D.、Garibaldi, R. A.、Krueger, G. G.(1978)。Stevens-Johnson syndrome aasociated with mycoplasma pneumoniae infections。Archives of Dermatology,114(2),241-244。  new window
9.Bottiger, L. E.、Strandberg, I.、Westerholm, B.(1975)。Drug-induced Febrile Mucocutaneous Syndrome。Acta Medica Scandinavica,198(3),229-233。  new window
10.Martin-Munoz, F.、Moreno-Ancillo, A.、Diaz-Pena, J. M.、Dominguez-Noche, C.、Garcia-Ara, C.、Boyano, T.、Ojeda, J. A.(1999)。Evaluation of drug-related hypersensitivity reactions in children。Journal of Investigational Allergology & Clinical Immunology,9(3),172-177。  new window
11.Wong, K. C.、Kennedy, P. J.、Lee, S.(1999)。Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis。Australasian Journal of Dermatology,40(3),131-134。  new window
12.Bianchine, J. R.、Macaraeg, P. V. J. Jr.、Lasagna, L.、Azarnoff, D. L.、Brunk, S. F.、Hvidberg, E. F.、Owen, J. A. Jr.(1968)。Drugs as etiologic factors in the Stevens-Johnson syndrome。American Journal of Medicine,44(3),390-405。  new window
13.Yetiv, J. Z.、Bianchine, J. R.、Owen, J. A. Jr.(1980)。Etiologic factors of the Stevens-Johnson syndrome。Southern Medical Journal,73(5),599-602。  new window
14.Smith, H. R.、Croft, A. M.、Black, M. M.(1999)。Dermatological adverse effects with the antimalarial drug mefloquine: a review of 74 published case reports。Clinical & Experimental Dermatology,24(4),249-254.。  new window
15.Kauppinen, K.(1972)。Cutaneous reactions to drugs with special reference to severe bullous mucocutaneous eruptions and sulphonamides.mucocutaneous eruptions and sulphonamides。Acta Dermato-Venereologica,S68,1-89。  new window
16.O'Callaghan, J.、Jones, G.(1972)。Stevens-Johnson syndrome after serial-C medication。Medical Journal of Australia,1(14),695-696。  new window
17.Chosidow, O.、Dega, H.、Laporte, J. L.、Frances, C.、Herson, S.(1996)。Ginseng as a cause for Stevens-Johnson syndrome?。Lancet,347(9011),1344。  new window
18.Johnson, W. D.、Kayser, K. L.、Brenowitz, J. B.、Saedi, S. F.(1991)。A randomized controlled trial of allopurinol in coronary bypass surgery。American Heart Journal,121(1 Pt 1),20-24。  new window
19.Singer, J. Z.、Wallace, S. L.(1986)。The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality。Arthritis & Rheumatism,29(1),82-87。  new window
20.Tam, S.、Carroll, W.(1989)。Allopurinol hepatotoxicity。American Journal of Medicine,86(3),357-358。  new window
21.Naranjo, C. A.、Busto, U.、Sellars, E. M.、Sandor, P.、Ruiz, I.、Roberts, E. A.、Janecek, E.、Domecq, C.、Greenblatt, D. J.(1981)。A method for estimating the probability of adverse drug reaction。Clinical Pharmacology and Therapeutics,30(2),239-245。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE